RO4929097 inhibits NICD3 to alleviate pulmonary hypertension via blocking Notch3/HIF-2α/FoxM1 signaling pathway

Baeten JT, Lilly B (2017) Notch signaling in vascular smooth muscle cells. Adv Pharmacol 78:351–382

Article  CAS  PubMed  Google Scholar 

Crow JJ, Albig AR (2020) Notch family members follow stringent requirements for intracellular domain dimerization at sequence-paired sites. PLoS ONE 15(11):e0234101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fishman AP (1976) Hypoxia on the pulmonary circulation. How and where it acts. Circ Res 38(4):221–231

Article  CAS  PubMed  Google Scholar 

Fleming RJ (1998) Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol 9(6):599–607

Article  CAS  PubMed  Google Scholar 

Gallardo-Vara E, Ntokou A, Dave JM, Jovin DG, Saddouk FZ, Greif DM (2023) Vascular pathobiology of pulmonary hypertension. J Heart Lung Transplant 42(5):544–552

Article  PubMed  Google Scholar 

Han Q, Han F, Fan Y, Lian B, Xiao J, Sun W et al (2020) Notch3 is involved in the proliferation of renal cancer cells via regulation of cell cycle progression and HIF-2&alpha. Oncol Lett 20(6):1–1

Article  Google Scholar 

Huang T, Zhao C, Zhao Y, Zhou Y, Wang L, Hang D (2021) RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption. Aging 13(9):12526–12536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang L, Liu X, Li Z, Li X, Han Y, Liu C et al (2023) Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn. J Cardiovasc Pharmacol 81(3):232–239

Article  CAS  PubMed  Google Scholar 

Kato M, Staub NC (1966) Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res 19(2):426–440

Article  CAS  PubMed  Google Scholar 

Kopan R, Ilagan MX (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137(2):216–233

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwon MY, Hwang N, Park YJ, Perrella MA, Chung SW (2018) NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation. Oncotarget 9(16):12671–12681

Article  PubMed  PubMed Central  Google Scholar 

Lau EMT, Giannoulatou E, Celermajer DS, Humbert M (2017) Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol 14(10):603–614

Article  CAS  PubMed  Google Scholar 

Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P et al (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15(11):1289–1297

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Xu C, Zhang W, Cao Y, Ye J, Li B et al (2022) FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia. Cell Death Dis 13(7). https://doi.org/10.1038/s41419-022-05091-2

Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D et al (2009) Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res 69(19):7672–7680

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mccaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA et al (2021) Gamma secretase inhibitors in cancer: a current perspective on clinical performance. Oncologist 26(4):e608–e621

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morris HE, Neves KB, Montezano AC, Maclean MR, Touyz RM (2019) Notch3 signalling and vascular remodelling in pulmonary arterial hypertension. Clin Sci (Lond) 133(24):2481–2498

Article  CAS  PubMed  Google Scholar 

Olsauskas-Kuprys R, Zlobin A, Osipo C (2013) Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 6:943–955

CAS  PubMed  PubMed Central  Google Scholar 

Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L et al (2023) Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management. Lancet Respir Med 11(9):820–835

Article  PubMed  Google Scholar 

Pitulescu ME, Schmidt I, Giaimo BD, Antoine T, Berkenfeld F, Ferrante F et al (2017) Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. Nat Cell Biol 19(8):915–927

Article  CAS  PubMed  Google Scholar 

Poch D, Mandel J (2021) Pulmonary hypertension. Ann Intern Med 174(4):Itc49-itc64

Article  PubMed  Google Scholar 

Raghavan A, Zhou G, Zhou Q, Ibe JCF, Ramchandran R, Yang Q et al (2012) Hypoxia-Induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1. Am J Respir Cell Mol Biol 46(4):431–436

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shirai M, Sada K, Ninomiya I (1986) Effects of regional alveolar hypoxia and hypercapnia on small pulmonary vessels in cats. J Appl Physiol (1985) 61(2):440–448

Article  CAS  PubMed  Google Scholar 

Stenmark KR, Fagan KA, Frid MG (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99(7):675–691

Article  CAS  PubMed  Google Scholar 

Su Y, Lai Y-J, Chang G-J, Yeh Y-H, Pang J-HS, Huang C-C, Chen W-J (2015) Propylthiouracil attenuates experimental pulmonary hypertension via suppression of Pen-2, a key component of gamma-secretase. Plos One 10(9). https://doi.org/10.1371/journal.pone.0137426

Tajsic T, Morrell NW (2011) Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr Physiol 1(1):295–317

PubMed  Google Scholar 

Takebe N, Nguyen D, Yang SX (2014) Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther 141(2):140–149

Article  CAS  PubMed  Google Scholar 

Walter K (2021) Pulmonary hypertension. Jama 326(11):1116

Article  PubMed  Google Scholar 

Wang YX, Wang J, Wang C, Liu J, Shi LP, Xu M, Wang C (2008) Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells. J Membr Biol 223(3):151–159

Article  CAS  PubMed  Google Scholar 

Wang RR, Yuan TY, Wang JM, Chen YC, Zhao JL, Li MT et al (2022) Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective. Pharmacol Res 180:106238

Article  CAS  PubMed  Google Scholar 

Xu J, Cao D, Zhang D, Zhang Y, Yue Y (2020) MicroRNA-1 facilitates hypoxia-induced injury by targeting NOTCH3. J Cell Biochem 121(11):4458–4469

Article  CAS  PubMed  Google Scholar 

Yoo SJ, Lee HR, Kim J, Yoo IS, Park CK, Kang SW (2022) Hypoxia-inducible factor-2 alpha regulates the migration of fibroblast-like synoviocytes via oxidative stress-induced CD70 expression in patients with rheumatoid arthritis. Int J Mol Sci 23(4):2342

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Xie X, Zhu Y, Liu L, Feng W, Pan Y et al (2015) Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension. Exp Lung Res 41(8):435–443

Article  CAS  PubMed 

留言 (0)

沒有登入
gif